Medicine and Dentistry
Apremilast
100%
Mouth Ulcer
91%
Genital Ulcer
83%
Patient
83%
Diseases
75%
Pain
33%
Randomized Clinical Trial
33%
Adverse Event
25%
Visual Analog Scale
25%
Venous Ulcer
25%
Combination Therapy
16%
Therapeutic Procedure
16%
Relapse
16%
Follow up
8%
Biological Product
8%
Informed Consent
8%
Disease Activity
8%
Life
8%
Evaluation Study
8%
Student T Test
8%
Statistical Analysis
8%
Paracetamol
8%
Disease Duration
8%
Diarrhea
8%
Immunosuppressive Drug
8%
Tertiary Care
8%
Wilcoxon Signed Ranks Test
8%
Off-Label Use
8%
Selection Bias
8%
Phosphodiesterase IV Inhibitor
8%
Hospital
8%
Observation
8%
Joint
8%
Quality of Life
8%
Female
8%
Pharmacology, Toxicology and Pharmaceutical Science
Apremilast
100%
Mouth Ulcer
91%
Genital Ulcer
83%
Diseases
75%
Pain
33%
Adverse Event
25%
Ulcer
25%
Relapse
16%
Case Report
16%
Biological Product
8%
Diarrhea
8%
Immunosuppressive Agent
8%
Disease Activity
8%
Paracetamol
8%
Disease Duration
8%
Phosphodiesterase IV Inhibitor
8%
Off-Label Use
8%
Symptom
8%